Construction of chimeric simian and human immunodeficiency viruses that produce interleukin 12

被引:15
作者
Kuwata, T [1 ]
Miura, T [1 ]
Haga, T [1 ]
Kozyrev, I [1 ]
Hayami, M [1 ]
机构
[1] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan
关键词
D O I
10.1089/088922200309124
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chimeric simian and human immunodeficiency viruses (SHIVs) are useful for evaluating vaccine candidates against HIV-1 and for investigating the pathogenesis of HIV-1 in vivo. In addition, SHIVs are candidates for a vaccine against HIV-1 because attenuated SHIVs can induce long-lasting anti-HIV-1 Env humoral and cell-mediated immunity in monkeys without AIDS-like diseases. In this study, we inserted IL-12 genes in a nef-deleted SHIV to increase the ability of the SHIV to induce cell-mediated immunity against HIV-1. The SHIV vector was constructed by deleting the nef gene and replacing it with restriction enzyme sites. Since IL-12 consists of two subunit genes, p35 and p40, SHIV's with one or both of these genes were constructed. SHIV's with either one of the subunit genes could replicate without a deletion of the inserted gene, but SHIVs with two subunit genes replicated poorly and the inserted genes were rapidly deleted. Production of IL-12 was detected when both of the single-subunit SHIVs were coinfected, The production of 1L-12 by the coinfection reached 800 pg/ml, and 1L-12 was detected after serial passage in cell cultures, although this amount of IL-12 heterodimer was 150-1500 times less than that of the p40 subunits, These IL-12-producing SHIVs are candidates for a live-attenuated vaccine to induce effective cellular immunity against HIV-1.
引用
收藏
页码:465 / 469
页数:5
相关论文
共 21 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   TH1 AND TH2 CYTOKINE PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIV-INFECTED PATIENTS [J].
BARCELLINI, W ;
RIZZARDI, GP ;
BORGHI, MO ;
FAIN, C ;
LAZZARIN, A ;
MERONI, PL .
AIDS, 1994, 8 (06) :757-762
[3]   INTERLEUKIN-12 PRODUCTION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
DANDREA, A ;
MA, XJ ;
TRINCHIERI, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) :1-5
[4]   INTERLEUKIN-12 - A BRIDGE BETWEEN INNATE RESISTANCE AND ADAPTIVE IMMUNITY WITH A ROLE IN INFECTION AND ACQUIRED IMMUNODEFICIENCY [J].
CHEHIMI, J ;
TRINCHIERI, G .
JOURNAL OF CLINICAL IMMUNOLOGY, 1994, 14 (03) :149-161
[5]   HUMAN IMMUNODEFICIENCY VIRUS-INFECTION OF MONOCYTIC AND T-LYMPHOCYTIC CELLS - RECEPTOR MODULATION AND DIFFERENTIATION INDUCED BY PHORBOL ESTER [J].
CLAPHAM, PR ;
WEISS, RA ;
DALGLEISH, AG ;
EXLEY, M ;
WHITBY, D ;
HOGG, N .
VIROLOGY, 1987, 158 (01) :44-51
[6]   Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection [J].
Clerici, M ;
Balotta, C ;
Meroni, L ;
Ferrario, E ;
Riva, C ;
Trabattoni, D ;
Ridolfo, A ;
Villa, M ;
Shearer, GM ;
Moroni, M ;
Galli, M .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (11) :1053-1061
[7]   Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques [J].
Giavedoni, L ;
Ahmad, S ;
Jones, L ;
Yilma, T .
JOURNAL OF VIROLOGY, 1997, 71 (02) :866-872
[8]   Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon [J].
Giavedoni, LD ;
Yilma, T .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2247-2251
[9]   Construction, replication, and immunogenic properties of a Simian immunodeficiency virus expressing interleukin-2 [J].
Gundlach, BR ;
Linhart, H ;
Dittmer, U ;
Sopper, S ;
Reiprich, S ;
Fuchs, D ;
Fleckenstein, B ;
Hunsmann, G ;
StahlHennig, C ;
Uberla, K .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2225-2232
[10]   A new approach to AIDS research and prevention: The use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines [J].
Haga, T ;
Kuwata, T ;
Ui, M ;
Igarashi, T ;
Miyazaki, Y ;
Hayami, M .
MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (04) :245-251